Search results
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 2 days agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
The nine things every man should know about prostate cancer
The Telegraph via Yahoo News· 3 days agoOpening up about their below-the-belt health is not a conversation every man wants to have with his...
Prostate cancer: How a plant-based diet can improve sexual health
Medical News Today· 3 days agoResearchers are reporting that a plant-based diet can ease side effects from prostate cancer...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 5 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
New trial will aim to find best way to screen men for prostate cancer
PA Media: Science via Yahoo News· 4 days ago“We must now prove that there are better ways to find aggressiveprostate cancer that will save even...
Prostate Cancer Cases Might Rise to 3 Million Globally by 2040
Journal of the American Medical Association· 1 day agoThe number of people diagnosed with prostate cancer will more than double worldwide over the next 2 decades, from 1.4 million in 2020 to 2.9 million by ...
Kate Beckinsale praises King Charles for ‘being really open’ about his cancer diagnosis
The Independent via Yahoo News· 24 hours agoAnd turn up when we are sick and sit with us... And send balloons and check in and pull us out of...
‘Game-changing’ prostate cancer screening could cut deaths by 40pc
Daily Telegraph· 4 days agoThe trial’s second stage, involving up to 300,000 men, will test the most promising options from ...
DNA tests could help spot men most at risk of ‘under the radar’ prostate cancer
The US Sun· 6 days agoSCIENTISTS are developing a DNA test to tell if a man’s prostate cancer will come back. Patients who...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
WKBN 27 Youngstown· 23 hours agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT ...